The road ahead: potential challenges facing CRISPR/Cas patents

Since Anton van Leeuwenhoek first discovered bacteria, these tiny single-cell organisms have been pivotal to major scientific advances. In fact, some of the biggest advances in medicine can be attributed to these unicellular microorganisms.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

ITC concludes row over biotech lab equipment between US and German rivals

USPTO clarifies AI's role in patent eligibility

Sanofi and Regeneron triumph in UPC decision against Amgen

The road ahead: potential challenges facing CRISPR/Cas patents

Editor's picks

Editor's picks

More features